Many studies have demonstrated that PTEN plays an important role in the development of prostate cancer, whose genomic deletion is closely associated with poor outcome of localized and androgen-independent prostate cancer [15], [16], [17]. The gene discussed is PTEN; the disease is prostate carcinoma.